These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9244203)

  • 1. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.
    Gupta S; Leatham EW; Carrington D; Mendall MA; Kaski JC; Camm AJ
    Circulation; 1997 Jul; 96(2):404-7. PubMed ID: 9244203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
    O'Connor CM; Dunne MW; Pfeffer MA; Muhlestein JB; Yao L; Gupta S; Benner RJ; Fisher MR; Cook TD;
    JAMA; 2003 Sep; 290(11):1459-66. PubMed ID: 13129985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).
    Stone AF; Mendall MA; Kaski JC; Edger TM; Risley P; Poloniecki J; Camm AJ; Northfield TC
    Circulation; 2002 Sep; 106(10):1219-23. PubMed ID: 12208796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease.
    Jafarzadeh A; Esmaeeli-Nadimi A; Shariati M
    Iran J Immunol; 2008 Mar; 5(1):51-6. PubMed ID: 18319525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chlamydia pneumoniae and Helicobacter pylori infections in acute myocardial infarction].
    Di Tano G; Picerno I; Calisto ML; Delia SA; Lagana P; Spataro P
    Ital Heart J Suppl; 2000 Dec; 1(12):1576-81. PubMed ID: 11221586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction.
    Ridker PM; Kundsin RB; Stampfer MJ; Poulin S; Hennekens CH
    Circulation; 1999 Mar; 99(9):1161-4. PubMed ID: 10069783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and effect on anti-Chlamydia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease.
    Jackson LA; Stewart DK; Wang SP; Cooke DB; Cantrell T; Grayston JT
    J Antimicrob Chemother; 1999 Sep; 44(3):411-4. PubMed ID: 10511413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.
    Muhlestein JB; Anderson JL; Carlquist JF; Salunkhe K; Horne BD; Pearson RR; Bunch TJ; Allen A; Trehan S; Nielson C
    Circulation; 2000 Oct; 102(15):1755-60. PubMed ID: 11023928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ACADEMIC study in perspective (Azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia).
    Anderson JL; Muhlestein JB
    J Infect Dis; 2000 Jun; 181 Suppl 3():S569-71. PubMed ID: 10839761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of Chlamydia pneumoniae infection in cyclosporin A-induced post-transplant gingival overgrowth tissue and evidence for the possibility of persistent infection despite short-term treatment with azithromycin.
    Worm HC; Wirnsberger GH; Mauric A; Holzer H
    Nephrol Dial Transplant; 2004 Jul; 19(7):1890-4. PubMed ID: 15128877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.
    Gattone M; Iacoviello L; Colombo M; Castelnuovo AD; Soffiantino F; Gramoni A; Picco D; Benedetta M; Giannuzzi P
    Am Heart J; 2001 Oct; 142(4):633-40. PubMed ID: 11579353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study.
    Siscovick DS; Schwartz SM; Corey L; Grayston JT; Ashley R; Wang SP; Psaty BM; Tracy RP; Kuller LH; Kronmal RA
    Circulation; 2000 Nov; 102(19):2335-40. PubMed ID: 11067785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.
    Cercek B; Shah PK; Noc M; Zahger D; Zeymer U; Matetzky S; Maurer G; Mahrer P;
    Lancet; 2003 Mar; 361(9360):809-13. PubMed ID: 12642046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem.
    Kark JD; Leinonen M; Paltiel O; Saikku P
    Int J Epidemiol; 1997 Aug; 26(4):730-8. PubMed ID: 9279604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity.
    Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
    Circulation; 2002 Nov; 106(19):2428-33. PubMed ID: 12417538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Chlamydia pneumoniae in the etiology of acne rosacea: response to the use of oral azithromycin.
    Fernandez-Obregon A; Patton DL
    Cutis; 2007 Feb; 79(2):163-7. PubMed ID: 17388221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that Chlamydia pneumoniae affects platelet activity in patients with acute myocardial infarction and ST-segment elevations.
    Järemo P
    Scand J Infect Dis; 2001; 33(10):747-8. PubMed ID: 11728040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.